Alicea-Torres, K., Sanseviero, E., Gui, J., Chen, J., Veglia, F., Yu, Q., Donthireddy, L., Kossenkov, A., Lin, C., Fu, S., Mulligan, C., Nam, B., Masters, G., Denstman, F., Bennett, J., Hockstein, N., Rynda-Apple, A., Nefedova, Y., Fuchs, S. Y., & Gabrilovich, D. I. (2021). Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway.
Nature Communications,
12(1), 1717.
https://doi.org/10.1038/s41467-021-22033-2 Cite